Review of the Fibrinolytic System: Comparison of Different Antifibrinolytics used During Cardiopulmonary Bypass

E-ISSN： 2212-3962|7|3|175-179

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.7, Iss.3, 2012-12, pp. : 175-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is a normal lactate level during cardiopulmonary bypass?

By Svenmarker Staffan Häggmark Sören Östman Margareta

Scandinavian Cardiovascular Journal, Vol. 40, Iss. 5, 2006-10 ,pp. : 305-311

Informa Healthcare

Access to resources Recommend Favorite

Actual Knowledge of Systemic Inflammation Reaction During Cardiopulmonary Bypass

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 3, 2012-12 ,pp. : 165-169

Bentham Science Publishers

Access to resources Recommend Favorite

Bivalirudin: Alternative Anticoagulation During Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 20-24

Bentham Science Publishers

Access to resources Recommend Favorite

Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass—Current and Future Directions

Current Cardiology Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 123-139

Bentham Science Publishers

Access to resources Recommend Favorite

Measurement of intraperitoneal metabolites during hypothermic cardiopulmonary bypass using microdialysis

By Adluri Rajeshwara K. P. Singh Arvind V. Skoyles Julian Baker Mya Mitchell Ian M.

Scandinavian Cardiovascular Journal, Vol. 45, Iss. 4, 2011-08 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite